We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DRUGMAKERS FOCUSED ON RISK MANAGEMENT, WELCOME NEW GUIDANCES
DRUGMAKERS FOCUSED ON RISK MANAGEMENT, WELCOME NEW GUIDANCES
May 6, 2004
Drugmakers are welcoming the FDA’s new draft guidances on risk management strategies, noting the documents will help them better understand the agency’s expectations in an increasingly important area for the pharmaceutical industry.